American Portfolios Advisors Standard Biotools Inc. Transaction History

American Portfolios Advisors

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Mar 21, 2023	BUY	$2.8 - $3.96 $979 - $1,386	350 New	350 $1.26 Million
Q4 2021 Mar 21, 2023	BUY	$3.63 - $6.13 $1,270 - $2,145	350 New	350 $1.37 Million
Q3 2021 Mar 22, 2023	BUY	$5.5 - $7.41 $3,025 - $4,075	550 New	550 $3.63 Million
Q2 2021 Mar 22, 2023	BUY	$4.35 - $6.35 $5,872 - $8,572	1,350 New	1,350 $8.32 Million
Q1 2021 Mar 22, 2023	BUY	$3.94 - $7.09 $5,319 - $9,571	1,350 New	1,350 $6.1 Million
Q4 2020 Mar 22, 2023	BUY	$5.45 - $8.65 $7,357 - $11,677	1,350 New	1,350 $8.1 Million
Q3 2020 Mar 22, 2023	BUY	$4.34 - $11.43 $5,859 - $15,430	1,350 New	1,350 $10 Million
Q2 2020 Mar 24, 2023	BUY	$1.85 - $5.29 $6,845 - $19,573	3,700 New	3,700 $14.8 Million

143

279M

27.2K

34.1K

Ticker LAB
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 78,654,800
Market Cap $131M
Description
Standard BioTools Inc. creates, manufactures, and markets instruments, consumables, reagents, and software for researchers and clinical laboratories worldwide. It offers analytical systems, such as Helios, a CyTOF system, as well as Hyperion imaging systems, Hyperion tissue imagers, and flow conductors; and assays and reagents, including Maxpar ...

Get notified when there are updates to the investment portfolio of American Portfolios Advisors, based on Form 13F filings with the SEC.

Stay updated on American Portfolios Advisors with notifications on news.